Fig. 6: Summary of genomic alterations in two patients had both pre- and post-treatment samples following BRAF-targeted agents.

In the comparison of pre- and post-treatment for patient ATC01, eight genes were found to have a gain in copy number, while no changes were observed in patient ATC12.